Study to Examine the Effect of HKI-272 on Rhythms of the Heart (Cardiac Repolarization)
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: neratinib|OTHER: Placebo|DRUG: Moxifloxacin
Sponsor: Puma Biotechnology, Inc.